Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Sernova Corp (SEOVF)

Sernova Corp (SEOVF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 315,156
  • Shares Outstanding, K 262,630
  • Annual Sales, $ 0 K
  • Annual Income, $ -5,540 K
  • 60-Month Beta 1.17
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 13.99
Trade SEOVF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings -0.02 on 03/29/22
  • Next Earnings Date 06/24/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0400 +15.38%
on 05/09/22
1.3700 -12.41%
on 05/17/22
+0.1200 (+11.11%)
since 04/27/22
3-Month
1.0400 +15.38%
on 05/09/22
1.3700 -12.41%
on 05/17/22
-0.0071 (-0.59%)
since 02/25/22
52-Week
0.9155 +31.08%
on 09/02/21
1.7560 -31.66%
on 01/07/22
+0.1400 (+13.21%)
since 05/27/21

Most Recent Stories

More News
Sernova and Evotec Enter into an Exclusive Global Strategic Partnership for iPSC-Based Beta Cell Replacement Therapy to Develop and Commercialize a ‘Functional Cure’ for Diabetes

Partnership Leverages Sernova’s Proprietary Cell Pouch System™ with Evotec’s iPSC-Based Insulin-Producing Beta CellsPartners to Develop and Commercialize...

SVA.VN : 1.520 (unch)
SEOVF : 1.2000 (+0.31%)
Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing

Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations

OTCM : 56.8000 (+1.81%)
SEOVF : 1.2000 (+0.31%)
SHGFF : 5.6450 (+1.71%)
BABYF : 1.0800 (+1.89%)
CRTPF : 2.3000 (+5.50%)
VVIVF : 0.2210 (-5.56%)
AVCNF : 0.3145 (+11.60%)
ORXOY : 1.8800 (+2.73%)
DOC.VN : 0.410 (-3.53%)
SVA.VN : 1.520 (unch)
SHG.VN : 6.800 (+5.92%)
BABY.VN : 1.170 (unch)
Sernova to Webcast Live at Life Sciences Investor Forum March 25th

Sernova invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.com

OTCM : 56.8000 (+1.81%)
SEOVF : 1.2000 (+0.31%)
SVA.VN : 1.520 (unch)
Virtual Conference for Life Sciences Companies Broadcast Live March 25th, 2021

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com

OTCM : 56.8000 (+1.81%)
SEOVF : 1.2000 (+0.31%)
SHGFF : 5.6450 (+1.71%)
BABYF : 1.0800 (+1.89%)
XRTXF : 0.4387 (-1.50%)
CRTPF : 2.3000 (+5.50%)
VVIVF : 0.2210 (-5.56%)
AVCNF : 0.3145 (+11.60%)
ORXOY : 1.8800 (+2.73%)
SVA.VN : 1.520 (unch)
SHG.VN : 6.800 (+5.92%)
BABY.VN : 1.170 (unch)
AgeX Therapeutics and Sernova to Collaborate to Engineer Universal Locally Immune Protected Cell Therapies for Type I Diabetes and Hemophilia A

AgeX Therapeutics, Inc. (“AgeX”: NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, and Sernova Corp. (TSX-V:SVA)(OTCQB:SEOVF)(FSE:PSH), a clinical-stage...

SVA.VN : 1.520 (unch)
SEOVF : 1.2000 (+0.31%)
AGE : 0.7800 (+11.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 1.2367
2nd Resistance Point 1.2233
1st Resistance Point 1.2117
Last Price 1.2000
1st Support Level 1.1867
2nd Support Level 1.1733
3rd Support Level 1.1617

See More

52-Week High 1.7560
Fibonacci 61.8% 1.4349
Fibonacci 50% 1.3357
Fibonacci 38.2% 1.2366
Last Price 1.2000
52-Week Low 0.9155

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar